Aim Approximately 20% of patients treated with neoadjuvant chemoradiotherapy (nCRT) for
locally advanced rectal cancer achieve a pathological complete response (p CR) while the …

Abstract Resistance to 5-fluorouracil (5-FU), an important anticancer drug, is a serious
challenge in the treatment of pancreatic cancer. Equilibrative nucleoside transporter 1 and …

Purpose: Molecular properties associated with complete response or acquired resistance to
concurrent chemotherapy and radiotherapy (CRT) are incompletely characterized …

Introduction: Pathological complete response (pCR) rates of approximately 20% following
neoadjuvant long-course chemoradiotherapy for rectal cancer have given rise to non …

Introduction Preoperative chemoradiotherapy represents the standard treatment for patients
with locally advanced rectal cancer. Unfortunately, the response of individual tumors to …

Standard treatment of patients with locally advanced rectal cancer (LARC) includes
neoadjuvant chemoradiotherapy (NCRT) followed by surgery. Tumor regression after NCRT …

The increasing and intensifying ultraviolet B (UVB) radiation in sunlight is an environmental
threat to aquatic ecosystems, potentially affecting the entire life cycle of wild or aquacultural …

Preoperative chemoradiation therapy (CRT) is the standard treatment for patients with
locally advanced rectal cancer (LARC) and can improve local control and survival outcomes …

Locally advanced rectal cancer is currently treated with pre-operative radiochemotherapy
(pRCT), but the response is not uniform. Identification of patients with higher likelihood of …

Preoperative chemoradiotherapy (CRT) combined with surgery has become a standard
treatment strategy for patients with locally advanced rectal cancer (LARC). The pathological …